Scinai Immunotherapeutics Closes Loan Restructuring Agreement with European Investment Bank
Scinai Immunotherapeutics closes loan restructuring agreement with the European Investment Bank, converting a significant loan amount into preferred shares. This development signals positive financial stability and future growth for the company.
This news matters as it highlights a significant financial restructuring for Scinai Immunotherapeutics, impacting the company's outstanding loan amount and signaling a positive development for the company's financial stability and future growth.
